Cancel

Honing in on the Appeal Process to Improve Access to Anti-VEGF Therapy for Patients with AMD

Step therapy requirements have limited patient access to FDA-approved, anti–vascular endothelial growth factor (VEGF) agents for the treatment of AMD. Prior authorization requests for these therapies are commonly denied. Hence, it is important that clinicians be aware of the approaches to overcome these barriers and implement systematic and clinically supported appeals that ensure uninterrupted anti-VEGF therapy for patients with AMD. In the third module of this CME Outfitters Snack seri...
CME Outfitters

Keeping the Patient in the Center in AMD Care

Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step the...
CME Outfitters

Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication

The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening disea...
CME Outfitters

Zooming In on the Education and Empowerment of Patients in AMD Care

FDA-approved agents that target vascular endothelial growth factor (VEGF) constitute important elements of optimal management of AMD. Prior authorization (PA) requirements limit patient access to these therapies. Navigating the PA process can be frustrating for patients, and may result in treatment abandonment leading to suboptimal outcomes. Hence, there is a need for patients to become advocates of their treatment choice. The final module of this CME Outfitters Snack series describes step ...
CME Outfitters

Sustained-Release Devices for the Treatment of Chronic Eye Diseases

Traditional topical drug delivery for the treatment of ocular diseases has a number of challenges including compliance; tearing and blinking, which results in medication spillage and drug dilution; tear film turnover; and inadequate absorption. In addition, medication noncompliance and loss to follow-up are additional common problems, especially for patients with with chronic diseases like age-related macular degeneration, diabetic macular edema and glaucoma. To combat these challenges to t...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 2

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives This educational activi...
Evolve Medical Education LLC

Navigating the World of Retina: Updates for the Newer Retina Specialist

Retinal disorders, including age-related macular degeneration (AMD) and diabetic macular edema (DME), can result in vision loss if not treated early and—in most cases—continuously. The need for newer retina specialists to be fully educated on the various treatment options remains crucial to delivering the best patient care. In addition, retina specialists new to practice must also navigate the business aspects of their clinics. TARGET AUDIENCE This certified CME activity is designed fo...
Evolve Medical Education LLC

Optimizing Patient Outcomes in Diabetic Retinopathy

Target Audience Content and educational strategies have been designed to facilitate behavior change in ophthalmologists, primary care physicians, residents and fellows, physician assistants, nurse practitioners, optomistrists, and all health care providers (HCPs) who care for patients at risk for diabetes and associated retinal disease. Learning Objectives Upon completion of this activity, participants should be able to: Identify and compare current treatment pathways for diabetic ...
MedicusCME

Cases in Prevention: Where the Latest Research on Diabetic Retinopathy Meets the Real World

Program Overview Diabetic retinopathy can now be treated earlier to prevent vision-threatening complications. This activity reviews the latest data and strategies. Learning Objectives Upon completion of this activity, participants should be able to: 1. Evaluate the evidence supporting treatment for preventing vision-threatening outcomes in diabetic retinopathy 2. Design treatment plans for diabetic retinopathy that consider individual patient factors 3. Describe clinical trial data s...
Jointly provided by Wills Eye Hospital and MedEdicus LLC

Tailoring Therapy to the Neovascular AMD Patient: Implementing Novel Treatment Strategies to Improve Outcomes

By 2040, an estimated 228 million people worldwide will be diagnosed with age-related macular degeneration (AMD). Treatment with anti-VEGF intravitreal injections has been shown to improve vision by 6 to 10 letters from baseline, but real-world results differ from clinical trial results. Therefore, it is clear that retina specialists need to be fully educated on the various treatment options to deliver the best patient care.
Evolve Medical Education LLC

Insight into Real-World Treatment of nAMD

Retinal disorders, including age-related macular degeneration, diabetic eye disease, and retinal vein occlusion can result in vision loss if not treated early and continuously. Prevent Blindness America has found the total health care costs of vision problems in the United States in people older than 40 years to reach almost $139 billion annually. Retina specialists must be continuously educated on the latest advances relating to the management of these diseases to allow for the best possible ...
Evolve Medical Education LLC

Diabetic Macular Edema Management

Diabetes is the leading cause of new cases of blindness among adults age 18 to 64 years, according to the Centers for Disease Control and Prevention’s 2020 National Diabetes Statistics Report. This activity reviews the management of patients with diabetic macular edema, with a focus on 1- and 2-year results of the Protocol T clinical trial.
Evolve Medical Education LLC

Relieving the Treatment Burden: Insights Into the Future of Anti-angiogenic Therapies for Neovascular AMD

Target Audience This activity is intended for retina specialists and comprehensive ophthalmologists who treat diseases of the retina. Program Overview This symposium recording will review current challenges associated with frequent anti-vascular endothelial growth factor (VEGF) therapy, including the impact on patients, caregivers, and treating physicians. The impact of undertreatment on visual acuity will be discussed. Finally, new anti-VEGF and other anti-angiogenic compounds that a...
Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare.

Inside the Doctor’s Studio: Retina

Target Audience The educational design of this activity addresses the needs of Retina Specialists, Retina Fellows, Ophthalmologists (general/comprehensive), Optometrists, Allied health involved in the treatment of patients with neovascular age-related macular degeneration (AMD). Statement of Need/Program Overview Include paragraph defining the purpose/need of the activity. Learning Objectives After completing this activity, the participant should be better able to: Discuss th...
Global Education Group and Avlis International, Inc

Gene Therapy: An Emerging Frontier in the Treatment of Neovascular Diseases

CONTENT SOURCE This continuing medical education (CME) activity captures content from a roundtable discussion. ACTIVITY DESCRIPTION There is potential for gene therapy to effectively treat neovascular diseases and eliminate the significant treatment burden. This roundtable discussion includes a review of the latest data, potential utility, and remaining questions surrounding this novel approach for management of neovascular age-related macular degeneration (nAMD).
Evolve Medical Education LLC

AMD Essentials and an RVO Review

This activity focuses primarily on studies that highlight all of the anti-VEGF dosing paradigms investigated in large, randomized clinical trials for the treatment of neovascular age-related macular degeneration plus two case presentations. A brief review of study results for retinal vein occlusion is also included. PRIMARY AUDIENCE: Retina specialists involved in the treatment and management of patients with retina disorders.
Evolve Medical Education LLC

The Relationship Between Fluid and BCVA

This activity will review the latest data on how intraretinal fluid and subretinal fluid in the retinal pigment epithelium affects visual acuity in patients with neovascular macular degeneration. PRIMARY AUDIENCE: Retina specialists involved in the treatment and management of patients with retina disorders.
Evolve Medical Education LLC

Fundamentals of DR/DME

In the following online activity you will learn about the fundamental trials and treatments on diabetic retinopathy and diabetic macular edema, plus two case presentations from experts in the field of retina. PRIMARY AUDIENCE: Retina specialists involved in the treatment and management of patients with retina disorders.
Evolve Medical Education LLC

The Basics of nAMD Treatment

This certified CME activity is designed for retina specialists and eye care professionals involved in the medical management of patients with retina disorders.
Evolve Medical Education LLC

Osler Ophthalmology Online Review

After completing the Osler Ophthalmology Online Review, you will be able to: • Apply the basic principles of optics to refractory problems and how to correct them • Describe the anatomy and physiology of each separate unit of the eye • Discuss common ocular conditions and delineate how to correlate clinical and pathologic findings • Diagnose and manage common types of congenital and acquired disorders in children • Explain the process of cataract surgery and potential complicati...
Osler Institute

Current and Future Treatments in Age-Related Macular Degeneration: 2019 Year in Review

CONTENT SOURCE This continuing medical education (CME) activity captures content from a roundtable discussion. ACTIVITY DESCRIPTION Newer classes of drugs are being evaluated to treat age-related macular degeneration (AMD), along with longer duration of currently approved drugs. This supplement reviews the expanding therapeutic innovations and improved diagnostic technologies. TARGET AUDIENCE This certified CME activity is designed for ophthalmologists and retina specialists involved ...
Evolve Medical Education LLC

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.